A Phase 2, Observer-blind, Randomized, Controlled Study to Evaluate the Safety and Immunogenicity of Two Formulations of Investigational Meningococcal Groups ACYWX Conjugate Vaccine, Administered to Healthy Malian Children 12-16 Months of Age
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 24 Apr 2018
At a glance
- Drugs Pentavalent-meningococcal-conjugate-vaccine-A-C-Y-W-135-X-Serum-Institute (Primary) ; Meningococcal vaccine groups A C Y W-135 conjugate
- Indications Meningococcal infections
- Focus Adverse reactions
- Sponsors Serum Institute of India
- 17 Apr 2018 Planned primary completion date changed from 1 May 2018 to 1 Jul 2018.
- 17 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 06 Nov 2017 Status changed from not yet recruiting to recruiting.